TherapeuticsMD
TXMD
#10727
Rank
S$27.02 M
Marketcap
S$2.34
Share price
-5.24%
Change (1 day)
16.56%
Change (1 year)

EPS for TherapeuticsMD (TXMD)

EPS in 2026 (TTM): S$0.10

According to TherapeuticsMD's latest financial reports the company's current EPS (TTM) is S$0.10. In 2021 the company made an earnings per share (EPS) of S-$28.00 an increase over its 2020 EPS that were of S-$43.22.

EPS history for TherapeuticsMD from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$0.10
2021S-$28.00-35.22%
2020S-$43.22-5.63%
2019S-$45.8020.34%
2018S-$38.0655.26%
2017S-$24.51-19.15%
2016S-$30.32-6%
2015S-$32.2542.86%
2014S-$22.5852.17%
2013S-$14.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$0.92 787.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$7.55 7,214.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
S-$4.99-4,937.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
S$1.97 1,811.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
S-$32.62-31,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA